Status:
COMPLETED
Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
University Ghent
Belgian Federation Against Cancer
Conditions:
Peritoneal Carcinomatosis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this project is to investigate the extent and role of mesothelial - mesenchymal transition (MMT) and cancer associated fibroblasts (CAFs) in the pathogenesis of colorectal peritoneal carci...
Eligibility Criteria
Inclusion
- • Patients presenting with colorectal peritoneal carcinomatosis
Exclusion
- Pregnancy or breast feeding
- Psychiatric pathology capable of affecting comprehension and judgment faculty
- HIPEC (hyperthermic intraperitoneal chemotherapy) or PIPAC (pressurized intraperitoneal aerosol chemotherapy) in the past
- Abdominal radiation treatment
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2022
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03777943
Start Date
November 1 2017
End Date
March 28 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000